Skip to main content

CASTLE BIOSCIENCES INC

For the period ended Aug 5, 2024. Filed Aug 5, 2024.

View on SEC.gov

About this filing

A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.

Aug 5, 2024 · Filed Aug 5, 2024

Use the contents to explore the available documents and sections.

CSTL$32.52-4.9%Stored close · as of Nov 6, 2026
See the whole filing, with its images and exhibits

EX-99.1 · (in thousands, except per share data)

(in thousands, except per share data)

Three Months Ended June 30,Six Months EndedJune 30,
2024202320242023
NET REVENUES$87,002$50,138$159,976$92,175
OPERATING EXPENSES
Cost of sales (exclusive of amortization of acquired intangible asset)14,51911,05828,41321,240
Research and development14,13613,30827,94527,701
Selling, general and administrative51,08844,68199,58391,443
Amortization of acquired intangible asset2,2472,2484,4944,470
Total operating expenses, net81,99071,295160,435144,854
Operating income (loss)5,012(21,157)(459)(52,679)
Interest income3,1442,3996,1404,735
Interest expense(270)(3)(284)(7)
Income (loss) before income taxes7,886(18,761)5,397(47,951)
Income tax (benefit) expense(1,034)16(989)30
Net income (loss)$8,920$(18,777)$6,386$(47,981)
Earnings (loss) per share:
Basic$0.32$(0.70)$0.23$(1.80)
Diluted$0.31$(0.70)$0.22$(1.80)
Weighted-average shares outstanding:
Basic27,64626,73327,56626,670
Diluted28,73826,73328,54226,670
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.